Long Island Jewish Medical Center

Other

The Rockefeller University

Sloan-kettering Institute for Cancer Research

Progenics Corporation

H Leon Bradlow

Fred I Chaslow

Fred I Chasalow

Martin Fleisher

Norman Applezweig

Peter M Ross

Morton K Schwartz

A method for determining whether a woman with gross cystic disease will develop breast cancer is provided. The method comprises analyzing human breast cyst fluid for the presence of a unique factor which has a retention time on an Amino Carbohydrate HPLC column of between about 6.4 minutes and about 6.7 minutes. The presence of this factor is diagnostically predictive for breast cancer.

Diagnostic assay for breast cancer in human female patients

A biologically active agent extracted from female breast cyst fluids displays anti-hypertensive activity in mammals. The agent is also useful in the treatment of congestive heart disease, artial fibrillation and idiopathic edema in mammals.

Biologically active agent having antihypertensive activity in mammals

A biologically active agent extracted from female breast cyst fluids displays anti-hypertensive activity in mammals. The agent is also useful in the treatment of congestive heart disease, atrial fibrillation and idiopathic edema in mammals.

Biologically active agent having anti-hypertensive activity in mammals

Glucocorticoid carboxylic acid esters and topical compositions thereof are utilized in methods for modulating cutaneous delayed hypersensitivity. Formulations of the glucocorticoid carboxylic acid esters are disclosed including incorporation into percutaneous drug delivery devices.

Compositions that affect suppression of cutaneous delayed

Methods and compositions are disclosed for inducing an incresed blood level of alpha-etiocholanolone in the body of a mammal in need of such treatments comprising administering to said mammal an amount of etiocholanedione effective to induce said increased blood level.

Increasing the bioavailability of alpha-etiocholanolone

A method for screening breast cyst fluid to identify patients having a high risk of developing breast cancer, comprising the steps of measuring the chloride ion content of breast cyst fluid aspirated from the patient; and correlating the chloride ion concentration with the risk of developing breast cancer.

Growing community of inventors

Holliswood, NY, United States of America

H Leon Bradlow